Don’t let knee pain keep you on the sidelines of life.

If osteoarthritis knee pain is making it harder to move, stay active, or enjoy the moments that matter, Reviscon® Mono 2.0% may help.

Person playing pickleball at the net
Stay in the game

The conversation is worth having.

Ask your healthcare provider whether Reviscon® Mono 2.0% is right for you.

  • Drug-free, steroid-free therapy
  • Relief may last up to 6 months
  • Non-animal origin
  • Health Canada approved

Reviscon® Mono 2.0% is a single-injection hyaluronic acid treatment from Germany designed to help cushion and lubricate osteoarthritic joints for lasting relief. Talk with your healthcare provider to see whether Reviscon® Mono 2.0% is right for you.

Daily life with knee OA

You usually notice it in ordinary moments first.

Knee pain rarely changes everything at once. It starts showing up in the routines that used to feel automatic.

Those everyday changes are often the clearest reason to ask whether another option is worth discussing.

Person climbing stairs

Climbing stairs

At home, at work, or anywhere the elevator starts looking easier.

Person carrying grocery bags

Grocery runs

Parking, lifting, loading, and the trip back into the house.

Person walking a dog

Walking the dog

What used to be automatic becomes something to plan around.

Person getting out of a car

Getting out of the car

That first step after a long drive tells you a lot.

Why ask about Reviscon

A clearer product story to bring to the appointment.

If you are comparing options for knee OA, it helps to understand not only what Reviscon® Mono 2.0% is used for, but what is worth asking about in its formulation.

This keeps the education grounded in what most patients want to know: how it relates to pain, mobility, treatment fit, and the kind of conversation they want to have with their healthcare professional.

A natural-profile option

Reviscon® Mono 2.0% is a linear, non-cross-linked hyaluronic acid option. Hyaluronic acid is a substance naturally found in healthy joints, where it helps with lubrication and shock absorption. Because it is not chemically cross-linked, it may have a lower likelihood of post-injection inflammation compared with cross-linked alternatives.

Focused on knee OA symptoms

For people with OA knee pain, Reviscon® Mono 2.0% is used to help reduce pain and stiffness and improve mobility.

Drug-free, steroid-free therapy

It offers a treatment conversation that is distinct from steroids, opioids, or day-to-day oral pain medication.

Single injection, relief may last up to 6 months

Reviscon® Mono 2.0% is administered directly into the knee joint by a qualified healthcare professional, and relief may last up to six months.

Common questions

Questions to bring up and what to expect

A few practical questions covering fit, timing, treatment, and recovery.

What is Reviscon® Mono 2.0% used for?

Reviscon® Mono 2.0% is a hyaluronic acid viscosupplement used to help reduce knee osteoarthritis pain and stiffness and improve mobility.

For patients, that means it is an injection-based option to discuss when knee OA is affecting comfort, movement, and daily life. Health Canada lists Reviscon® Mono 2.0% as an active Class III medical device under Licence No. 110891.

Could Reviscon® Mono 2.0% be right for my knee OA?

Reviscon® Mono 2.0% may be a relevant treatment to discuss with your healthcare professional if knee osteoarthritis pain, stiffness, or reduced mobility is affecting your daily life.

It may be a particularly useful conversation if:

  • your knee OA symptoms are limiting movement, walking, stairs, work, or activities you want to keep doing;
  • you want to ask about a single-injection hyaluronic acid viscosupplement;
  • you are looking for a steroid-free and non-opioid injection option;
  • you are trying to reduce reliance on oral pain medication;
  • you are exploring non-surgical options for osteoarthritis symptom relief;
  • previous conservative measures have not provided enough relief;
  • your healthcare professional believes viscosupplementation is appropriate for your affected knee.

A qualified healthcare professional must assess your knee OA, medical history, symptoms, and treatment goals before deciding whether Reviscon® Mono 2.0% is appropriate for you.

How is Reviscon® Mono 2.0% given?

Reviscon® Mono 2.0% is administered directly into the knee joint by a qualified healthcare professional. This type of injection is called an intra-articular injection, meaning the treatment is placed into the joint space.

Reviscon® Mono 2.0% is supplied as a 2.4 mL single-use glass syringe containing 20.0 mg/mL sodium hyaluronate. It is designed as a single-injection viscosupplement.

How long might it take to feel results?

Improvement is usually gradual. Hyaluronic acid injections are not typically positioned as same-day numbing treatments. They are intended to support joint lubrication and function over time.

Some patients notice improvement over the following weeks. Your healthcare professional can help set expectations based on your knee, symptoms, activity level, and osteoarthritis severity, including what to expect after treatment and when to follow up.

How long might relief last?

Response varies from person to person. Viscosupplementation injections can provide relief for an average of six months, but results depend on the individual, the affected joint, osteoarthritis severity, activity level, and treatment history.

Your healthcare professional can help you understand what duration of relief is realistic for your situation and whether repeat treatment should be considered. Arthritis Society Canada notes that viscosupplementation is not routinely recommended for all osteoarthritis patients because benefits, risks, and costs need to be weighed carefully.

Does Reviscon® Mono 2.0% contain drugs like steroids or opioids?

Reviscon® Mono 2.0% is steroid-free and non-opioid. It is a hyaluronic acid viscosupplement, not a corticosteroid injection and not an oral pain medication.

It is also a linear, non-cross-linked hyaluronic acid option. Hyaluronic acid is similar to a substance naturally found in joints, where it helps with lubrication and shock absorption, and the non-cross-linked structure may have a lower likelihood of post-injection inflammation compared with cross-linked alternatives.

Ask your doctor or pharmacist

Bring the guide. Ask clearly.

Bring a short list of questions to the appointment so the conversation stays focused on pain, movement, and daily life.

  • Ask whether Reviscon® Mono 2.0% could be right for your OA knee pain.
  • Talk through what treatment involves and what recovery looks like.
  • Discuss how long it may take to feel results and how long relief may last.
  • Keep the conversation centered on movement, comfort, and daily life.

go.reviscon.ca/oa · For informational purposes only.

Patient reviewing treatment information with their doctor

Start the conversation prepared

Bring the guide to focus your questions on goals, expectations, and next steps.